KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxlinear (MXL) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Maxlinear (MXL) over the last 17 years, with Q4 2025 value amounting to $72.8 million.

  • Maxlinear's Cash & Equivalents fell 3859.92% to $72.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $72.8 million, marking a year-over-year decrease of 3859.92%. This contributed to the annual value of $72.8 million for FY2025, which is 3859.92% down from last year.
  • Per Maxlinear's latest filing, its Cash & Equivalents stood at $72.8 million for Q4 2025, which was down 3859.92% from $111.9 million recorded in Q3 2025.
  • Over the past 5 years, Maxlinear's Cash & Equivalents peaked at $224.6 million during Q2 2023, and registered a low of $72.8 million during Q4 2025.
  • For the 5-year period, Maxlinear's Cash & Equivalents averaged around $157.8 million, with its median value being $160.3 million (2021).
  • As far as peak fluctuations go, Maxlinear's Cash & Equivalents skyrocketed by 7544.16% in 2021, and later tumbled by 4643.95% in 2025.
  • Over the past 5 years, Maxlinear's Cash & Equivalents (Quarter) stood at $130.6 million in 2021, then surged by 43.49% to $187.4 million in 2022, then decreased by 0.03% to $187.3 million in 2023, then tumbled by 36.69% to $118.6 million in 2024, then plummeted by 38.6% to $72.8 million in 2025.
  • Its Cash & Equivalents was $72.8 million in Q4 2025, compared to $111.9 million in Q3 2025 and $108.6 million in Q2 2025.